All In Biotech

Drug Trial Radar · NCT06807281

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

A Phase 3, Multicenter, Long-Term, Open Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Dec 2, 2025

Primary completion

Feb 22, 2032

Study completion Feb 22, 2032

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Feb 4, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe atopic dermatitis. The study will enroll two groups: participants who have completed other abrocitinib studies and participants who have never participated in abrocitinib studies.

Conditions

  • Atopic Dermatitis

Interventions

  • AbrocitinibDrug

    Abrocitinib administered as liquid oral suspension.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), and adverse events (AEs) that lead to study discontinuationTime frame: 0-24 months

Locations

40 sites in 7 countries. Site status is shown where the registry gives one.

  • Cahaba Dermatology & Skin Health Center

    Birmingham, Alabama · Recruiting

  • Arkansas Research Trials

    North Little Rock, Arkansas · Recruiting

  • Investigational Drug Service - Rady Childrens Hospital-San Diego

    San Diego, California · Recruiting

  • University of California, San Diego/ Rady Children's Hospital - San Diego

    San Diego, California · Recruiting

  • Solutions Through Advanced Research

    Jacksonville, Florida · Recruiting

  • Ada West Research - Meridian

    Meridian, Idaho · Recruiting

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana · Recruiting

  • Saint Louis University

    St Louis, Missouri · Recruiting

  • Medical University of South Carolina - South Carolina Translational Research Nexus Clinic

    Charleston, South Carolina · Recruiting

  • Tribe Clinical Research, LLC

    Greenville, South Carolina · Recruiting

  • Texas Dermatology and Laser Specialists

    San Antonio, Texas · Recruiting

  • Shanghai Children's Hospital

    Shanghai, China · Recruiting

  • Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine

    Shanghai, China · Recruiting

  • Beijing Children's hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Shenzhen Children's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • Hunan Children's Hospital

    Changsha, Hunan, China · Recruiting

  • Dermatology Hospital of Jiangxi Province

    Nanchang, Jiangxi, China · Not yet recruiting

  • Hangzhou Third People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Pécsi Tudományegyetem Klinikai Központ

    Pécs, Baranya, Hungary · Recruiting

  • Trial Pharma Kft.

    Békéscsaba, Bekes County, Hungary · Recruiting

  • University of Szeged

    Szeged, Csongrád-csanád, Hungary · Not yet recruiting

  • Clinexpert Kft.

    Budapest, Pest County, Hungary · Recruiting

  • Fukuoka National Hospital

    Fukuoka, Japan · Recruiting

  • Saruta Dermatology Clinic

    Fukuoka, Japan · Recruiting

  • Queen's square Medical Facilities Queen's square Dermatology and Allergology

    Yokohama, Kanagawa, Japan · Recruiting

  • Dermatology and Ophthalmology Kume Clinic

    Sakai, Osaka, Japan · Recruiting

  • Sasamoto Children's Clinic

    Setagaya-ku, Tokyo, Japan · Recruiting

  • Servicios Hospitalarios de Mexico S.A. DE C.V.

    Chihuahua City, Mexico · Not yet recruiting

  • Hospital Infantil de Mexico Federico Gomez

    Mexico City, Mexico City, Mexico · Not yet recruiting

  • Eukarya Pharmasite S.C.

    Monterrey, Nuevo León, Mexico · Not yet recruiting

  • Arké SMO S.A de C.V

    Veracruz, Veracruz Ignacio de LA Llave, Mexico · Not yet recruiting

  • Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Marek Brzewski, Paweł Brzewski spółka cywilna

    Krakow, Lesser Poland Voivodeship, Poland · Recruiting

  • Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak

    Lodz, Łódź Voivodeship, Poland · Recruiting

  • LUXDERM Specjalistyczny Gabinet Dermatologiczny prof. dr hab. n. med. Dorota Krasowska

    Lublin, Lublin Voivodeship, Poland · Recruiting

  • Centrum Medyczne Evimed

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • DERMAPOLIS Medical Dermatology Center dr n. med. Edyta Gebska

    Chorzów, Silesian Voivodeship, Poland · Recruiting

  • Dermedic Jacek Zdybski

    Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, Poland · Recruiting

  • Hospital Universitario Miguel Servet

    Zaragoza, Spain · Recruiting

  • CHUS - Hospital Clinico Universitario

    Santiago de Compostela, A Coruña [LA Coruña], Spain · Recruiting

  • Hospital General de Granollers

    Granollers, Barcelona, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.